Synergistic effects of probiotics and low-FODMAP diet on clinical and inflammatory outcomes in ulcerative colitis: a retrospective cohort study.

Shan Jia¹, XiaoLong Yu², BaoSheng Bao³, BinBin Liu¹

¹Twelve Wards of Zhejiang Hospital Sandun Campus, Zhejiang, China.

²Department of Nutrition, Zhejiang Hospital, Zhejiang, China.

³Department of Rheumatology and Immunology, Zhejiang Hospital, Zhejiang, China.

PubMed PMC DOI PDF

Abstract

BACKGROUND: Ulcerative colitis (UC) is a chronic inflammatory bowel disease characterized by mucosal inflammation, in which gut dysbiosis and immune imbalance play pivotal roles. Dietary and microbiota-targeted interventions, particularly the low-FODMAP (fermentable oligosaccharides, disaccharides, monosaccharides, and polyols) diet and probiotics, have individually shown benefits in symptom contr…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Create Free Account Sign In

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.